Efficacy of Mepolizumab Extended Interval Dosing For Two Asthmatic Cases with Chronic Eosinophilic Pneumonia. Sato H, Miyata Y, Inoue H, Tanaka A, et al. J Investig Allergol Clin Immunol 2021 Jan 26:0. doi: 10.18176/jiaci.0671.

Read + Share

Amedeo Smart

Independent Medical Education

Sato H, Miyata Y, Inoue H, Tanaka A, et al. Efficacy of Mepolizumab Extended Interval Dosing For Two Asthmatic Cases with Chronic Eosinophilic Pneumonia. J Investig Allergol Clin Immunol 2021 Jan 26:0. doi: 10.18176/jiaci.0671.
PMID: 33502319